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A B S T R A C T   
The burden of disability among survivors and the socio-economic impact of snakebite have not been adequately 
researched. We reviewed original research articles, case reports and small case series relating to chronic physical, 
mental and psycho-social disability and economic burden of snakebite. Both physical and psychological health 
problems seem common in snakebite survivors and can lead to disability and loss of productivity. Chronic 
physical health effects, musculoskeletal disability being the commonest, can be largely attributed to limited and 
delayed access to optimal treatment of acute envenoming. The economic burden is considerable, and includes 
health system costs, out-of-pocket expenditure and opportunity costs, with regional variations. Health systems 
should be more responsive to needs and circumstances of bite victims, and a more holistic approach should be 
developed in the treatment of snakebite which incorporates the management of chronic health effects.   
1. Introduction 
Snakebite envenoming causes significant morbidity and mortality in 
tropical and subtropical countries in Africa, Asia, Oceania and Latin 
America (Kasturiratne et al., 2008). Most of the morbidity and mortality 
occurs in young adults living and working in farming and other labour 
intensive occupations in impoverished rural areas. The combination of 
poor access to often sub-optimal health services, scarcity of effective and 
safe antivenom, and the burden placed on families and communities due 
to snakebite victims with disability, many of whom are young and 
economically productive, is very likely to result in a considerable 
medical, social and economic toll (Hansdak et al., 1998). Despite their 
importance, neither the burden of disability among survivors nor the 
socio-economic impact of snakebite have been adequately researched. 
Most snakebite-related research is focussed on the epidemiology and 
clinical aspects of acute envenoming and mortality, which understand-
ably take priority in countries struggling with inadequate resources to 
manage and save the lives of snakebite victims. Although recommen-
dations have been made that assessments of snakebite burden should 
include chronic disability and related socio-economic costs, obtaining 
reliable data on these aspects is challenging. There are several reasons 
for this. Snakebite envenoming mainly occurs in the poorest regions of 
the world (Harrison et al., 2009) and the available data are usually based 
on incomplete hospital returns or central databases (Kasturiratne et al., 
2008). Snakebites are often underreported because many victims may 
seek traditional treatments, either due to preference or inadequate or 
absent allopathic treatment facilities (Pugh et al., 1980; Snow et al., 
1994; Rahman et al., 2010; Ediriweera et al., 2017). Furthermore, there 
is rarely, if ever, routine follow-up of snakebite victims who are dis-
charged from hospital after the acute complications of envenoming have 
resolved and, with loss of further contact, the allopathic system fails to 
detect possible longer-term disabilities and their consequences. 
In Asian, African and Latin American countries, there are many 
studies which report that health workers lack sufficient knowledge and 
confidence in snakebite management (Fung et al., 2009; Sapkota et al., 
2020; Inthanomchanh et al., 2017; Gajbhive et al., 2019). The problem 
stems from deficiencies in the training of these professionals in their 
medical or nursing courses (Inthanomchanh et al., 2017; Kharusha et al., 
2020). Chronic disability following snakebite is more likely to occur, 
both, where there is poor access to healthcare and in situations where 
management of the bite is inadequate. In such settings follow-up of 
victims is extremely unlikely to occur. 
While improved medical management has the potential to reduce 
chronic physical disability, for example, reduce the rate of limb ampu-
tations or severe disfigurement, psychological disability following a 
snakebite may yet occur (Williams et al., 2011). Adverse physical effects 
of envenoming are related to the necrotoxic, neurotoxic and hema-
totoxic damage caused by venom components, but the mechanisms by 
which snake envenoming causes psychological disability has not been 
explored. 
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Although the allopathic system, in general, loses contact with 
snakebite victims after their discharge from hospital, some survivors 
can, and do, continue to seek help from traditional healers who are easy 
to access and offer them social and psychological support which takes 
into account the religious and cultural beliefs of local communities. 
Research on chronic disability following snakebite may, therefore, 
benefit from the inclusion of traditional healers (Stienstra et al., 2021). 
In this paper we review the available published literature on chronic 
physical, mental and psycho-social disability and economic burden of 
snakebite. 
2. Methods 
2.1. The search strategy 
This review was conducted according to the PRISMA 2020 statement 
for reporting systematic reviews (Page et al., 2021). To identify original 
research papers published on chronic health effects of snakebite, we 
searched PubMed, Scopus and EBSCOhost databases using the terms 
“snake bite” OR “snakebite” AND “health effects” OR “morbidity” OR 
“disability” OR “sequelae” OR “consequences” AND “long term” OR 
“chronic” OR “delayed”. This search resulted in 1247 research papers. 
829 remained after duplicates were merged. Of these, 229 were book or 
book sections. Remaining 600 journal articles and thesis were screened 
using the abstract and 41 and 75 were excluded due to being animal 
studies and reviews, respectively. The remaining 484 publications were 
screened for relevance and content. PubMed, EBSCOhost and Scopus 
databases and the specific journals websites were used to retrieve the 
full papers. 472 full papers and 12 abstracts were retrieved and 
reviewed. 59 papers contained data on chronic health effects of snake-
bite (Fig. 1). Health outcomes prevalent at the time of discharge from 
the hospital and reported as persistent at least 4 weeks after discharge 
and outcomes attributed to the index snakebite that occur after 
discharge from the hospital and persist for a minimum of 4 weeks from 
discharge were considered. 
We conducted a separate search in PubMed, EBSCOhost and Scopus 
(limited to subject areas: Medicine and Economics, Econometrics and 
Finance) databases using the terms “snake bite” OR “snakebite” AND 
“economic” OR “cost” OR “expenditure” OR “burden”. This search 
resulted in 1855 scientific publications. 1523 remained after duplicates 
were merged. 96 book chapters and book sections were excluded. 
Remaining 1427 papers were evaluated for relevance through screening 
the abstract. This resulted in identifying 325 potentially relevant pub-
lications. 318 full papers and 7 abstracts were reviewed to identify 15 
papers describing the out-of-pocket expenditure or the cost of snakebite 
for the health system at hospital, country or regional level (Fig. 2). 
3. Results 
We reviewed 59 original research papers to identify information on 
chronic health effects of snakebite and 15 papers that dealt with its cost. 
Fig. 1. PRISMA 2020 flow diagram for reviewing the chronic health effects of snakebite.  
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3.1. Chronic health effects of snakebite 
Chronic or long-term health effects of snakebite has many definitions 
in the available literature. They include, any condition related to 
snakebite that required follow-up after discharge from hospital, condi-
tions that last or appear more than six weeks following envenoming, or 
health problems that had occurred immediately or within 4 weeks of the 
bite and had persisted for more than 3 months (Williams et al., 2011; 
Jayawardana et al., 2018; Waiddyanatha et al., 2019; Brenes-Chacon 
et al., 2020). 
Chronic physical health effects of snakebite can be broadly classified 
into dermatological, musculoskeletal, neurological, renal and endocrine 
conditions. Chronic psychological health effects include a broad group 
of mental health problems. These are summarized in (Table 1). 
3.2. Chronic physical health effects 
Skin blistering after snakebite envenoming often results in the 
development of necrotic lesions which are difficult to treat, especially in 
the context of poorly resourced health care facilities in areas where 
snakebite is common, where surgical expertise and antibiotics are in 
short supply and hospital conditions favour secondary infection. 
Chronic non-healing ulcers and persistent or recurrent blisters at the bite 
site, though rare, are the most commonly reported dermatological 
conditions (Jayawardana et al., 2016; Jayawardana et al., 2018). 
Hypertrophic scars, which may cause contractures leading to disfig-
urement and functional limitations even requiring reconstructive sur-
gery, and hyper-pigmentation and discolouration of skin in the affected 
part of the body, have also been commonly reported. Excessive hair loss 
has also been reported rarely. Musculo-skeletal disabilities are the 
commonest chronic condition associated with snakebite. Weakness, 
functional limitation and deformities of the affected limbs due to muscle 
dystrophy are commonly reported (Caiaffa et al., 1994; Jayawardana 
et al., 2016; Rodríguez and Gutiérrez, 2019). Tissue necrosis leading to 
amputation of parts of the affected limb is the most severe and debili-
tating chronic condition associated with snakebite globally [Kidmas 
et al., 2004; Tsai et al., 2017]. There does not seem to be consistency in 
the use of surgical techniques emphasizing the need for standardization 
(Sachett et al., 2020b). 
A migraine-like syndrome characterized by headache, blurred vision, 
nausea and dizziness has been described (Jayawardana et al., 2018). 
Other neurological conditions with long-lasting impact such as visual 
and hearing impairment, paresthesia at the bite site, and persistence of 
hemiparesis or hemiplegia due to cerebrovascular events at the time of 
acute envenoming have also been reported (Spano et al., 2014; Jaya-
wardana et al., 2018). Chronic renal failure requiring haemodialysis has 
been reported in some victims of snakebite who had developed acute 
kidney injury following the bite (Naqvi, 2016; Pucca et al., 2020). 
Establishing causality is challenging as most of these reports provide no 
information regarding the victims’ renal function prior to envenoming, 
Fig. 2. PRISMA 2020 flow diagram for reviewing the cost of snakebite.  
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Table 1 
Chronic health effects of snake bites.  
No Authors Location Long term health effects 
Physical Psychological 
1 Caiaffa et al. (1994) Southeast Brazil  • Muscle contractures  
• Amputations  
• Chronic renal failure 
Not reported 
2 Sharma et al. (2004) South Eastern Nepal  • Scar with deformity  
• Chronic wound 
Not reported 
3 Kidmas et al., 2004 Jos, Nigeria  • Gangrene  
• Amputation 
Not reported 
4 Bell et al. (2010) Teaching Hospital, Kurunegala, Sri Lanka  • Abnormal nerve conduction Not reported 
5 Williams et al. (2011) North Central Province, Sri Lanka  • Blindness  
• Tooth decay  
• Body aches  
• Headaches  
• Tiredness  
• Weakness.  
• Depressive disorder  
• Post-traumatic stress disorder 
6 Khosrojerdi and Amini 
(2013) 
Imam Reza Hospital, Iran Not reported  • Post-traumatic stress disorder 
7 Spano et al. (2014) UCSF-Fresno Medical Education Program 
Medical Centre, Fresno Central California  
• Localised pain at bite site  
• Numbness/paraesthesiae  
• Abnormal skin peeling and 
discolouration  
• Persistent weakness of the bitten 
extremity 
Not reported 
8 Wijesinghe et al. (2015) District General Hospital, Polonnaruwa, Sri 
Lanka 
Not reported  • Depression  
• Anxiety 
9 Habib et al. (2015) Northeastern Nigeria Not reported  • Post-traumatic stress disorder  
• Impaired family/school functioning  
• Psychological morbidity 
10 Jayawardana et al. (2016) Ampara, Sri Lanka  • Local pain in affected limb  
• Swelling of affected limb  
• Muscle wasting  
• Chronic non-healing ulcer  
• Chronic lump  
• Reduced muscle power  
• Reduced range of motion  
• Balance impairment  
• Abnormal gait  
• Fixed deformities  
• Amputation 
Not reported 
11 Naqvi (2016) Sindh Institute of Urology and 
Transplantation, Karachi, Pakistan  
• Chronic kidney disease Not reported 
12 Tsai et al., 2017 Chia-Yi Chang Gung Memorial Hospital in 
Taiwan  
• Necrotizing fasciitis Not reported 
13 Islam et al., 2017 Rangamati Sadar Hospital, Rangamati, 
Bangladesh  
• Numbness  
• Severe asthenia  
• Tingling  
• Generalized pain 
•Localised pain  
• Depression  
• Post-traumatic stress disorder  
• Anxiety 
14 Naik et al. (2018) Chandigarh, India  • Chronic pituitary failure Not reported 
15 Yerawar et al. (2020) Nanded, India  • Hypopitiutarism Not reported 
16 Proby et al. (1990) London, UK  • Anterior Pituitary Faliure Not reported 
17 Jayawardana et al. (2018) Ampara, Sri Lanka  • Migraine-like syndrome  
• Musculoskeletal disorders  
• Visual impairment  
• Chronic renal failure  
• Skin blisters at the bite site  
• Hemiplegia  
• Facial palsy  
• Local paresthesia  
• General shivering  
• Chronic non healing ulcer  
• Hearing loss  
• Excessive hair loss  
• Lassitude with body aches  
• Abdominal colic  
• Chest tightness  
• Wheezing  
• Receding gums  
• Psychological distress 
18 Arias-Rodríguez and 
Gutiérrez (2020) 
South-eastern (Brunca region) Costa Rica  • Functional limitation of affected limb  
• Amputation  
• Anxiety  
• Depression  
• Post-traumatic stress disorder 
19  
Brenes-Chacon et al. 
(2020) 
National Children’s Hospital in Costa Rica  • Hypertrophic scars needing skin graft  
• Functional limitation of affected limb  
• Deformity 
Not reported 
(continued on next page) 
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Table 1 (continued ) 
No Authors Location Long term health effects 
Physical Psychological  
• Amputation 
20 Sachett et al. (2020a) Brazil  • Disability in mobility  • Poor cognition  
• Disability in self-care, getting along, impact 
in life activities, participating in society 
21 Pucca et al. (2020) Las Claritas Bolívar, Venezuela  • Chronic Kidney Disease Not reported 
22 Pulimaddi et al. (2017) India  • Chronic Kidney Disease Not reported 
23 Priyamvada et al. (2019) Puducherry, India  • Chronic Kidney Disease Not reported 
24 Alcoba et al. (2020) Akonolinga health district, Centre Region, 
Cameroon  
• Amputation of distal phalanges  
• Ankylosis of phalanges  
• Tingling  
• Chronic recurrent pain  
• Subjective psychological trauma 
25 Kumar et al. (2018) Malabar, North Kerala, India  • Hypopituitarism  
• gangrene and amputation  
• Osteomyelitis  
• Intracranial hemorrhage and 
cerebrovascular accidents 
Not reported 
26 Brenes et al. (2018) National Children’s Hospital, Costa Rica  • Chronic lymphedema,  
• Functional impairment 
Not reported 
27 Pérez-Gómez et al. (2019) Western Brazilian Amazon  • Haemorrhagic stroke Not reported 
28 Sachett et al. (2020a) Guajará (Amazonas state), Western Brazilian 
Amazon  
• Haemorragic stroke Not reported 
29 Kim et al. (2021a) Chungnam National University Hospital, 
Daejeon, Korea  
• Skin necrosis  
• Rhabdomyolysis 
Not reported 
30 van Oirschot et al. (2021) Kajiado and Kilifi counties. Kenya  • Pain and numbness  
• Weakness or paralysis of the bitten area  
• Scarring  
• Amputation or permanent disability  
• Recurrent swelling  
• Recurrent wounds  
• Dizziness  
• Sleeping and breathing problems  
• Functional disability 
Not reported 
31 Kularatne (2002) Anuradhapura, Sri Lanka  • Nerve conduction defects  
• Sensory loss at the site of bite  
• Bilateral ulnar nerve palsy with wasting 
of small muscles of the hands  
• Sensory motor neuropathy  
• Cerebella ataxia  
32 Corneille et al. (2006) Texas, USA  • Amputation Not reported 
33 Yates et al. (2010) Meserani, Tanzania  • Amputation Not reported 
34 Herath et al. (2012) Kandy, Sri Lanka  • Chronic Kidney Faliure Not reported 
35 Namal Rathnayaka et al., 
2020 
Sri Lanka  • Chronic Kidney disease Not reported 
36 Seneviratne and 
Dissanayake (2002) 
Ratnapura and Polonnaruwa, Sri Lanka  • Peripheral sensory loss Not reported 
37 Elbey et al. (2017) Diyarbakır, Turkey  • Amputation Not reported 
38 Weinstein et al. (2018) Australia  • Amputation Not reported 
39 Zeng et al. (2019) Chongqing, P.R. China  • Skin necrosis  
• Rhabdomyolysis 
Not reported 
40 Halilu et al. (2019) Sub-Saharan Africa  • PTSD  
• Amputations 
Not reported 
41 Gerardo et al. (2019) Southeastern United States  • Functional disability Not reported 
42 Banerjee et al. (2019) India  • Cerebella ataxia Not reported 
43 Lizarazo et al. (2020) Catatumbo, Colombia  • Cerebral hemorrhage Not reported 
44 Srirangan et al. (2020) Kalubowila, Sri Lanka  • Gangreen leading to amputation  
• CRF 
Not reported 
45 Habib et al. (2021) North-eastern Nigeria Not reported  • Posttraumatic stress disorder  
• Poor QoL in psychological and social 
domains  
• Impaired family/school functioning  
• Psychological morbidity 
46 Kazemi et al. (2021) Iran  • Fasciotomy related long term morbidity Not reported 
47 Jelinek et al. (1998) Nedlands, Western Australia  • Renal insufficiency Not reported 
48 Chroni et al. (2005) Rion-Patras, Greece  • Neuropathy Not reported 
49 Sinha et al. (2009) Kolkata, India  • Chronic Kidney Disease Not reported 
50 Golay et al. (2014) West Bengal, India  • Chronic Kidney Disease  
• Hypopituitarism 
Not reported 
51 Mahmood et al. (2018) Mandalay Division, Myanmar  • Chronic renal failure  
• Chronically infected bite site wound  
• Hypopituitarism  
• Loss of a limb from amputation 
Not reported 
52 Lee and Yao (2010) Arizona, USA  • Stenosing flexor tenosynovitis Not reported 
53 Bonasso et al. (2015) West Virginia, USA  • Osteonecrosis at bite site Not reported 
54 Gelman et al. (2021) Texas, USA  • Septic arthritis at bite site Not reported 
(continued on next page) 
A. Kasturiratne et al.                                                                                                                                                                                                                           
Toxicon: X 9–10 (2021) 100074
6
and therefore the problem is neglected. Hypopituitarism and resulting 
disturbances in related hormones has been reported in snakebite victims 
lasting for many years after the bite (Naik et al., 2018). 
3.3. Delayed psychological effects 
Delayed psychological effects following snakebite have been poorly 
investigated. Depressive symptoms and post-traumatic stress disorder 
are the most common psychological conditions reported following 
snakebite (Khosrojerdi and Amini, 2013; Williams et al., 2011). 
Non-specific somatic manifestations of psychological problems resulting 
from the experience of snakebite, which may be related to socio-cultural 
beliefs that promote a sick role are also described in the literature 
(Rodríguez and Gutiérrez, 2019; Alcoba et al., 2020). 
3.4. Cost of snakebite 
The estimations of the cost of snakebite in the literature are sum-
marized in Table 2. 
The available estimates cover health system costs and out-of-pocket 
expenditure of snakebite (Hasan et al., 2012), and the burden of 
snakebite (Habib et al., 2015). The cost per death averted has been 
estimated for 16 countries in West Africa (Hamza et al., 2016). Using 
data on mortality and amputations, the total burden of snakebite in West 
Africa has been estimated at 320,000 DALYs (95% CI: 248,000–403,000 
DALYs) per year with Nigeria accounting for 43% of the burden (Habib 
et al., 2015). 
In Cameroon, the relatively expensive prices of AVS ranging from US 
$20–75 are unaffordable for households of the most vulnerable com-
munities (Tochie, 2017). Clinical protocols developed for standardiza-
tion of antivenom use has been effective for reducing the cost of care, by 
reducing the number of vials used and the length of hospital stay, with 
no significant difference in complication rates (Ghosh et al., 2008; 
Weant et al., 2012). However, in many regions in Africa, including 
Cameroon, the antivenoms have not been tested for effectiveness, and 
the efficacy of the antivenoms used is questionable. This issue needs to 
be addressed as a priority (Potet et al., 2019). 
Regional variations in the cost of care and the disease burden have 
been described within the most affected countries and across regions 
over the last 20 years (Kasturiratne et al., 2005; Habib et al., 2015; 
Curran-Sills and Kroeker, 2018). 
4. Discussion 
Snakebite is a debilitating condition both from a health and eco-
nomic perspective (Habib and Brown, 2018). As the condition is most 
prevalent in the most vulnerable populations living in low-income 
countries and, in addition to development of adverse chronic health 
effects, the extra cost incurred by a snakebite may have a devastating 
economic impact on the victims and their families (Harrison et al., 
2009). In this paper, we reviewed the available literature on the chronic 
health effects and costs of snakebite envenoming. 
Chronic health effects of snakebite, though likely to be commoner 
than reports indicate, have received limited attention in the snakebite 
literature. The wide variation in the definition of “chronic health effects” 
in relation to their point of appearance and duration, indicates the lack 
of a systematic approach to defining and describing this very important 
aspect of snakebite (Williams et al., 2011; Jayawardana et al., 2018; 
Waiddyanatha et al., 2019; Brenes-Chacon et al., 2020). Screening and 
detection of chronic disability related to snakebite would require at least 
one out-patient follow-up visit after victims are discharged from hos-
pital. The development of a set of patient-centred outcomes, based on 
the available evidence and expert consensus, would make the assess-
ment for chronic disability and its management more systematic and 
meaningful. 
The reported chronic physical health effects of snakebite can be 
largely attributed to delayed or lack of access to appropriate treatment, 
and inappropriate or sub-optimal treatment within health facilities due 
to limited resources or poor quality of care. Although “400,000 dis-
abilities caused by snakebites each year worldwide” is often cited in the 
recent literature, how this number was arrived at or details regarding 
the severity, offending species and which regions are worst affected are 
sparse. 
The most commonly reported is musculoskeletal disability. Persis-
tent limb swelling, probably the result of lymphatic or vascular injury, 
has been reported, especially after viper bites; 8/800 snakebites in Sri 
Lanka (Jayawardana et al., 2016), 19% after Malayan pit viper bites in 
Thailand (Wongtongkam et al., 2005). While most dermatological and 
musculo-skeletal damage, especially those related to venom related 
tissue necrosis, may lead to disfigurement, surgical interventions such as 
fasciotomy and amputations to treat compartment syndrome and sub-
sequent tissue necrosis have life-long consequences with severe 
disability and loss of productivity (Habib et al., 2015). Doppler Ultra-
sound is a useful tool to evaluate swelling and exclude compartment 
syndrome (Ho et al., 2021) and where available, may be a promising 
approach to avoid unnecessary fasciotomy. Another relatively simple 
intervention maybe physiotherapy, which is rarely done after snakebite, 
but will probably significantly improve the outcome and reduce the 
number and severity of chronic musculoskeletal disorders. At present 
there does not seem to be consistency in the use of surgical techniques, 
and standard protocols are urgently needed. 
Psychological problems may occur even after “successful” treatment 
of snake envenoming with AVS, and although difficult to detect without 
adequate follow-up, together with associated non-specific somatic 
manifestations, can have considerable negative social and economic 
impacts, for example, from loss of employment (Williams et al., 2011). A 
small randomized trial of a brief psychological intervention, that can be 
provided by non-specialist doctors, appeared to reduce psychiatric 
Table 1 (continued ) 
No Authors Location Long term health effects 
Physical Psychological 
55 Dhabhar et al. (2021) India  • B/L axonopathic Optic neuritis Not reported 
56 Pérez-Gómez et al. (2019) Western Brazilian Amazon  • Haemorrhagic stroke  
• Temporal hemianopsia  
• Headache  
• Tissue necrosis  
• Retinal haemorrhages  
• Skin ulcers  
• Visual defects  
• Hemipareisis 
Not reported 
57 Abraham et al. (2020) Kerala, India  • Muscle and joint weakness Not reported 
58 KIm et al. (2021b)" Republic of Korea  • Local tisssue necrosis  
• Scarring 
Not reported 
59 Gupta et al. (2021) Delhi, India  • Neuromuscular weakness Not reported  
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symptoms and disability related to family and social life after snakebite 
envenoming, but not depression or post-traumatic stress disorder 
(Wijesinghe et al., 2015). More research is required to develop 
culturally-appropriate interventions for those affected, especially 
focusing on post-traumatic stress disorder and depression following 
snakebite. 
There has been an increase in the number of studies reporting eco-
nomic burden of snakebite over the last ten years (after 2010). Out of 
pocket expenditure and opportunity costs incurred by victims and their 
families have been reported in several studies (Vaiyapuri et al., 2013; 
Kasturiratne et al., 2017; Magalhães et al., 2020). Hospital based studies 
commonly report the cost of care for a single episode of snakebite. 
Although there are wide variations in the cost across the regions of the 
world, developing treatment protocols may help to reduce the cost of 
care as well as the rates of complications that may lead to chronic 
disability (Ghosh et al., 2008; Weant et al., 2012). National level studies 
on the economic burden of snakebite and studies on the 
cost-effectiveness of anti-venom treatment have highlighted the prob-
lem of limited availability of AVS and the financial burden placed on 
poorer economies where snakebite is common, due to the cost of AVS. 
In conclusion, poor healthcare and limited access to anti-venom are 
the leading causes of morbidity and chronic disability due to snakebite 
envenoming. These can adversely impact the economy of poor com-
munities. Health systems need to be more responsive to the needs and 
circumstances of the victims of snakebite, developing a more holistic 
approach that incorporates the management of the acute manifestations 
of envenoming, preventing mortality, together with management of 
Table 2 
Cost of snakebite reported in global literature.  
Health system cost of snakebite 
No Author Location Cost  
Lopoo et al. (1998) USA  • US$2450 per child treated  
Hasan et al. (2012) Bangladesh  • Total expenditure of 
snakebite: US$4- US$2294 
(Mean = US$124).  
• Mean income loss: US$93.  
• Expenditure for venomous 
snakebite: US$231  
• Expenditure non- 
venomous snakebite: US 
$34  
Saz-Parkinson et al. 
(2012) 
Spain  • Mean: Euro2000 per case  





• Patients receiving anti- 
venom under observation 
status: US$17665  
• In-patients receiving anti- 
venom: US$20503  
Kasturiratne et al. 
(2017) 
Sri Lanka  • Annual estimated health 
system cost: US 
$10,260,651.53  
• Cost of anti-venom: US 
$6.3 million  
• Cost of hospital care: US 
$3.9 million  
Tochie (2017) Cameroon  • Cost of an AVS vial: US 
$67–75 or US$20–23  
Okumu et al., 2019 JOOTRH, Kisumu 
County, Western 
Kenya  
• The median cost of 
treating snakebite: 2652 
KES (US$26).  
Magalhães et al. 
(2020) 
Brazilian Amazon  • Health system cost: US 
$3.115.861,28.  
• The total cost: US$8 
million in 2015  




of Rabat, Morocco  
• The average direct 
medical costs: US$127/ 
child  
• The average direct non- 
medical costs: US$30/ 
child  
Khan et al. (2020) Saudi Arabia Direct healthcare cost per 
snakebite patient by severity 
category  
• Mild: SAR 15,005 (Mean 
= SAR 3750)  
• Moderate: SAR 87,707 
(Mean = SAR 29,444)  
• Severe: SAR 92,286 
(Mean = SAR 46,143)  
• Death: SAR 43,142 (Mean 
= SAR 43,142)  
• Total: SAR 238,140 
(Mean = SAR 26,460) 
Household cost of snakebite 
No Author Location Cost  
Sharma et al. 
(2004) 
South eastern Nepal  • Household cost: US$69 
(SD = 100)  
Vaiyapuri et al. 
(2013) 
Tamil Nadu, India  • The direct cost (transport 
and medical expenses): 
Rs.0–350,000 (£4858).  
Kasturiratne et al. 
(2017) 
Sri Lanka  • National direct out-of- 
pocket expenditure for 
snakebite: US$1,981,699  
Magalhães et al. 
(2020) 
Brazilian Amazon  • Cost from the patient’s 
perspective: US$268 
914.18. 
Burden of snakebite 
No Author Location Cost  
Habib et al. (2015) Nigeria  • The cost/death averted: 
$2330.16  
• The cost/DALY averted: 
$99.61 (discounted) and 
$56.88 (undiscounted)  
Hamza et al. (2016) West Africa  
Table 2 (continued ) 
Health system cost of snakebite 
No Author Location Cost 
The cost/death averted for 
Guinea Bissau: US$1997 
The cost/death averted for 
Liberia and Sierra Leone: US 
$6205 
The cost/DALY averted for 
Benin Republic: US$$83 
(95% Confidence Interval: 
US$36-$240) 
The cost/DALY averted for 
Sierra-Leone: US$281 
($159–457).  
Kasturiratne et al. 
(2017) 
Sri Lanka  • Total number of DALYs for 
envenoming and death: 
11, 101–15,076 per year  
• For males 5624–7927 
DALYs  
• For females 5477–7150 
DALYs  
• The total DALYs 
(snakebites without 
envenoming) - 20–500 per 
year  
• Total annual economic 
burden of snakebite: US 
$14,097,789  
Quintana-Castillo 
et al. (2020)   
• Cost-effectiveness ratio 
(CER) of treatment with 
AV for each death 
avoided: US$1253  
• Cost-effectiveness ratio 
(CER) of treatment with 
AV per DALY avoided US 
$51  
Magalhães et al. 
(2020) 
Brazilian Amazon  • The estimated cost due to 
premature death: US 
$3031 300.38.  
• The cost attributed to the 
loss of productivity: US 
$1539 518.62.  
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chronic health effects, both physical and psychological. Chronic health 
effects of snakebite and the economic cost of snakebite are inter-related 
and are a part of a vicious poverty cycle that deserves the highest 
attention of snakebite researchers, administrators and policy makers. 
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Saz-Parkinson, Z., del Pino Luengo, M., López-Cuadrado, T., Andújar, D., Carmona- 
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